The competitive dynamics in the healthcare and pharmaceutical industries are changing fast and industry players worldwide face growing competition and tougher regulation.

At Dillon Eustace, our multi-disciplinary Healthcare Group has broad experience and understanding of the domestic and global healthcare and pharmaceutical markets which enables us to provide clients with an industry focused approach which will ensure our clients successfully navigate risks and realise market opportunities.

Dillon Eustace has the depth of knowledge and experience to deliver innovative legal services to its clients to meet industry specific challenges at all times ensuring the highest quality advice and solutions.

Having cultivated an expertise in the healthcare and pharmaceutical industries and worked with many leading and emerging domestic and international pharmaceutical and healthcare providers, Dillon Eustace recognises the importance of anticipating regulatory and contractual issues in the context of corporate investment, finance and strategy.

As a full service law firm, Dillon Eustace can also provide leading tax, employment, and dispute resolution services to ensure the delivery of an integrated, cost-effective solution for its healthcare and pharmaceutical clients.

Dillon Eustace provides specialist advices on a range of high profile and complex issues, including:

Advices on interface with Government and regulatory authorities, including the HSE, the National Treatment Purchase Fund, the Health Information and Quality Authority, the European Commission and the Irish Competition Authority;
Judicial review of regulatory decisions;
Compliance and Codes of Conduct;
Corporate structuring;
Commercial agreements including contracts for the supply of goods and care services;
Data protection and freedom of information;
Consent and confidentiality;
Major restructurings including mergers;
Employment issues;
Corporate governance;

Dillon Eustace lawyers also regularly speak at industry conferences and publish in legal journals.

Experience

Acted for the acquirer in the M&A Deal of the Year, 2013 – advised Perrigo Company Plc on its recommended $8.6 billion offer for Elan Corporation Plc.
Advises the leading representative body for private and voluntary nursing homes in Ireland.
Advised United Drug Plc on its successful creditors’ petition placing three pharmacies in examinership.
Advises private and voluntary nursing homes in their on-going interface with the National Treatment Purchase Fund, the Health Information and Quality Authority and the HSE.
Advises a leading Irish health insurer.
Acted in the private equity backed management buy-out of a large Irish private healthcare group.
Advises Centric Health in relation to the establishment of community GP partnership practices and primary health care centres.
Advised the sellers in relation to the disposal of a number of pharmacies to the Lloyds Pharmacy network.